CVE-2012-2297

Description

Multiple cross-site scripting (XSS) vulnerabilities in the Creative Commons module 6.x-1.x before 6.x-1.1 for Drupal allow remote authenticated users with the administer creative commons permission to inject arbitrary web script or HTML via the (1) creativecommons_user_message or (2) creativecommons_site_license_additional_text parameter.

Category

2.1
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.35%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.madirish.net/content/drupal-creative-commons-6x-10-xss-vulnerability
http://www.securityfocus.com/bid/53248 vdb entry
http://www.openwall.com/lists/oss-security/2012/05/03/2 mailing list
http://secunia.com/advisories/48937 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/75180 vdb entry
http://www.openwall.com/lists/oss-security/2012/05/03/1 mailing list
http://drupal.org/node/1547520
http://drupal.org/node/1547478

Frequently Asked Questions

What is the severity of CVE-2012-2297?
CVE-2012-2297 has been scored as a low severity vulnerability.
How to fix CVE-2012-2297?
To fix CVE-2012-2297, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-2297 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-2297 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.